

Conatus Pharmaceuticals is focused on the development of human therapeutics to treat liver failures and cancer. Among its major competitors, Conatus Pharmaceuticals is ranked in 5th place for NPS while Biogen is 1st, and Athersys is 2nd.Their current market cap is $18.44M